ClinicalTrials.Veeva

Menu

Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction (PEPCADNSTEMI)

U

University Hospital, Saarland

Status and phase

Completed
Phase 4

Conditions

Coronary Heart Disease
NSTEMI

Treatments

Device: Stent
Combination Product: SeQuent(R) Please coated balloon

Study type

Interventional

Funder types

Other

Identifiers

NCT01489449
PEPCAD NSTEMI

Details and patient eligibility

About

The aim of the present trial is to assess the efficacy of the standalone use of SeQuent(R) Please coated balloon compared to a bare metal stent (BMS) in patients with NSTEMI.

Full description

The aim of the present trial is to assess the efficacy of the standalone use of SeQuent(R) Please coated balloon compared to a bare metal stent (BMS) in patients with NSTEMI. Primary efficacy endpoint will be MACE (cardiac mortality, reinfarction, and target lesion revascularization) after 9 months.

Enrollment

210 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NSTEMI with
  • Ischemic symptoms (angina pectoris) > 30 minutes
  • Last symptoms within 72 hours before randomization
  • Positive cardiac troponin T, I, or hs-Troponin above 99th percentile
  • age > 18 years
  • Identifiable culprit lesion without angiographic evidence of large thrombus with intended early PCI (treatment of up to two lesions allowed)

Exclusion criteria

  • Cardiogenic shock
  • ST-elevation myocardial infarction
  • No identifiable culprit lesion, Indication for acute bypass surgery
  • Comorbidity with limited life expectancy < 9-12 months
  • Contraindication for treatment with heparin, ASA and thienopyridines

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

210 participants in 2 patient groups, including a placebo group

Stent
Placebo Comparator group
Description:
Stent Implantation (DES or BMS), no further treatment
Treatment:
Device: Stent
DCB
Active Comparator group
Description:
"DEBonly" strategy: treatment with drug coated balloon, additional spot-stenting in case of severe dissection
Treatment:
Combination Product: SeQuent(R) Please coated balloon

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems